27 studies found for:    LY2216684
Show Display Options
Rank Status Study
21 Completed
Has Results
A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: LY2216684;   Drug: Methylphenidate;   Drug: Placebo (tablet);   Drug: Placebo (capsule)
22 Completed A Study for Patients With Major Depression
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo;   Drug: escitalopram
23 Completed A Study in Adult Patients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Placebo
24 Completed A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
25 Completed A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: LY2216684;   Drug: Placebo
26 Completed A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Placebo
27 Completed A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-27) Next Page   
Indicates status has not been verified in more than two years